Cargando…
Integration of Host Strain Bioengineering and Bioprocess Development Using Ultra-Scale Down Studies to Select the Optimum Combination: An Antibody Fragment Primary Recovery Case Study
An ultra scale-down primary recovery sequence was established for a platform E. coli Fab production process. It was used to evaluate the process robustness of various bioengineered strains. Centrifugal discharge in the initial dewatering stage was determined to be the major cause of cell breakage. T...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282095/ https://www.ncbi.nlm.nih.gov/pubmed/24838387 http://dx.doi.org/10.1002/bit.25259 |
_version_ | 1782351071259131904 |
---|---|
author | Aucamp, Jean P Davies, Richard Hallet, Damien Weiss, Amanda Titchener-Hooker, Nigel J |
author_facet | Aucamp, Jean P Davies, Richard Hallet, Damien Weiss, Amanda Titchener-Hooker, Nigel J |
author_sort | Aucamp, Jean P |
collection | PubMed |
description | An ultra scale-down primary recovery sequence was established for a platform E. coli Fab production process. It was used to evaluate the process robustness of various bioengineered strains. Centrifugal discharge in the initial dewatering stage was determined to be the major cause of cell breakage. The ability of cells to resist breakage was dependant on a combination of factors including host strain, vector, and fermentation strategy. Periplasmic extraction studies were conducted in shake flasks and it was demonstrated that key performance parameters such as Fab titre and nucleic acid concentrations were mimicked. The shake flask system also captured particle aggregation effects seen in a large scale stirred vessel, reproducing the fine particle size distribution that impacts the final centrifugal clarification stage. The use of scale-down primary recovery process sequences can be used to screen a larger number of engineered strains. This can lead to closer integration with and better feedback between strain development, fermentation development, and primary recovery studies. Biotechnol. Bioeng. 2014;111: 1971–1981. © 2014 Wiley Periodicals, Inc. |
format | Online Article Text |
id | pubmed-4282095 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BlackWell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-42820952015-01-15 Integration of Host Strain Bioengineering and Bioprocess Development Using Ultra-Scale Down Studies to Select the Optimum Combination: An Antibody Fragment Primary Recovery Case Study Aucamp, Jean P Davies, Richard Hallet, Damien Weiss, Amanda Titchener-Hooker, Nigel J Biotechnol Bioeng Articles An ultra scale-down primary recovery sequence was established for a platform E. coli Fab production process. It was used to evaluate the process robustness of various bioengineered strains. Centrifugal discharge in the initial dewatering stage was determined to be the major cause of cell breakage. The ability of cells to resist breakage was dependant on a combination of factors including host strain, vector, and fermentation strategy. Periplasmic extraction studies were conducted in shake flasks and it was demonstrated that key performance parameters such as Fab titre and nucleic acid concentrations were mimicked. The shake flask system also captured particle aggregation effects seen in a large scale stirred vessel, reproducing the fine particle size distribution that impacts the final centrifugal clarification stage. The use of scale-down primary recovery process sequences can be used to screen a larger number of engineered strains. This can lead to closer integration with and better feedback between strain development, fermentation development, and primary recovery studies. Biotechnol. Bioeng. 2014;111: 1971–1981. © 2014 Wiley Periodicals, Inc. BlackWell Publishing Ltd 2014-10 2014-06-04 /pmc/articles/PMC4282095/ /pubmed/24838387 http://dx.doi.org/10.1002/bit.25259 Text en © 2014 Wiley Periodicals, Inc. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Aucamp, Jean P Davies, Richard Hallet, Damien Weiss, Amanda Titchener-Hooker, Nigel J Integration of Host Strain Bioengineering and Bioprocess Development Using Ultra-Scale Down Studies to Select the Optimum Combination: An Antibody Fragment Primary Recovery Case Study |
title | Integration of Host Strain Bioengineering and Bioprocess Development Using Ultra-Scale Down Studies to Select the Optimum Combination: An Antibody Fragment Primary Recovery Case Study |
title_full | Integration of Host Strain Bioengineering and Bioprocess Development Using Ultra-Scale Down Studies to Select the Optimum Combination: An Antibody Fragment Primary Recovery Case Study |
title_fullStr | Integration of Host Strain Bioengineering and Bioprocess Development Using Ultra-Scale Down Studies to Select the Optimum Combination: An Antibody Fragment Primary Recovery Case Study |
title_full_unstemmed | Integration of Host Strain Bioengineering and Bioprocess Development Using Ultra-Scale Down Studies to Select the Optimum Combination: An Antibody Fragment Primary Recovery Case Study |
title_short | Integration of Host Strain Bioengineering and Bioprocess Development Using Ultra-Scale Down Studies to Select the Optimum Combination: An Antibody Fragment Primary Recovery Case Study |
title_sort | integration of host strain bioengineering and bioprocess development using ultra-scale down studies to select the optimum combination: an antibody fragment primary recovery case study |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282095/ https://www.ncbi.nlm.nih.gov/pubmed/24838387 http://dx.doi.org/10.1002/bit.25259 |
work_keys_str_mv | AT aucampjeanp integrationofhoststrainbioengineeringandbioprocessdevelopmentusingultrascaledownstudiestoselecttheoptimumcombinationanantibodyfragmentprimaryrecoverycasestudy AT daviesrichard integrationofhoststrainbioengineeringandbioprocessdevelopmentusingultrascaledownstudiestoselecttheoptimumcombinationanantibodyfragmentprimaryrecoverycasestudy AT halletdamien integrationofhoststrainbioengineeringandbioprocessdevelopmentusingultrascaledownstudiestoselecttheoptimumcombinationanantibodyfragmentprimaryrecoverycasestudy AT weissamanda integrationofhoststrainbioengineeringandbioprocessdevelopmentusingultrascaledownstudiestoselecttheoptimumcombinationanantibodyfragmentprimaryrecoverycasestudy AT titchenerhookernigelj integrationofhoststrainbioengineeringandbioprocessdevelopmentusingultrascaledownstudiestoselecttheoptimumcombinationanantibodyfragmentprimaryrecoverycasestudy |